are glp 1 specialty drugs Insights from Physicians on GLP-1RA Medications Off-Label Use Mapping the effectiveness and risks

Participants receiving once-weekly exenatide injections for 48 weeks showed modest improvements in motor scores compared to placebo, and these benefits persisted for 12 weeks after treatment cessation

Who Should (and Shouldn't) Use Retatrutide Since retatrutide isn't FDA-approved yet, there are no official prescribing guidelines

The Risks of Microdosing Microdosing is an off-label strategy that requires specific instructions that should be tailored to the individual, says Dr

During the consultation appointment, the patient and their provider will discuss their goal weight, medical history, and lifestyle

It can cause an array of bothersome side effects and is linked to serious health problems like gastroparesis, intestinal blockages, kidney failure, and thyroid cancer